Efficacy outcomes reported in trials of multiple sclerosis: A systematic scoping review-Reference-Cited by-同舟云学术

Efficacy outcomes reported in trials of multiple sclerosis: A systematic scoping review

Published:2020-10 Issue: Volume:45 Page:102435
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Oliveira Magda Laíse,Lucchetta Rosa Camila^ORCID,Bonetti Aline de Fátima,Fernandez-Llimós Fernando,Becker Jefferson,Gonçalves Marcus Vinícius Magno,Tauil Carlos Bernardo^ORCID,Pontarolo Roberto,Wiens Astrid^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference61 articles.

1. Fingolimod therapy in early multiple sclerosis: an efficacy analysis of the transforms and freedoms studies by time since first symptom;Agius;CNS Neurosci. Ther.,2014

2. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial;Arnold;BMC Neurol.,2017

3. Joanna Briggs Institute Reviewer's Manual;Aromataris,2017

4. Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis;Barkhof;Neurology,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitions of digital biomarkers: a systematic mapping of the biomedical literature;BMJ Health & Care Informatics;2024-04

2. Estimation of sample size in randomized controlled trials in multiple sclerosis studying annualized relapse rates: A systematic review;Multiple Sclerosis Journal;2021-10-26

3. Multiple sclerosis hospitalizations among users of oral disease-modifying therapies;Multiple Sclerosis and Related Disorders;2021-07

4. Safety and Efficacy of Fingolimod Compared to Placebo in the Treatment of Relapsing Multiple Sclerosis: A Systematic Review and Meta-analysis Study;Qom Univ Med Sci J;2021-02-01